Akèy › Kat vèt › Janssen Scientific Affairs, LLC
Janssen Scientific Affairs, LLC: sponso kat vèt (PERM)
Janssen Scientific Affairs, LLC te depoze 4 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 4. Mwayèn salè yo ofri $158,500; mwayèn tan soti nan depozisyon jiska sètifikasyon: 493 jou.
Aplikasyon PERM4
Sètifye4
Salè medyan ofri$158,500
Mwayèn jou pou sètifikasyon493
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)337
Nan biznis depi2004
Adrès anplwayèNew Brunswick, NJ
Salè H-1B nan Janssen Scientific Affairs, LLC →
Tit travay
| Tit travay | Aplikasyon PERM | Salè medyan |
|---|---|---|
| Manager, Real World Value & Evidence (REV&E), Oncology | 1 | $155,000 |
| Senior Medical Director Pipeline Innovation, Neuroscience | 1 | $340,000 |
| Manager, Market Access Analytics | 1 | $145,000 |
| Associate Director Value & Evid Scientific Engagement | 1 | $162,000 |
Kote travay
Okipasyon
- Medical and Health Services Managers1
- Natural Sciences Managers1
- Data Scientists1
- Project Management Specialists1
Dènye desizyon
| Tit travay | Salè baz | Kote | Soumèt | Deside | Estati | Jou |
|---|---|---|---|---|---|---|
| Associate Director Value & Evid Scientific Engagement | $162,000–$179,000 | Titusville, NJ | Apr 28, 2025 | Jun 4, 2026 | Sètifye | 402 |
| Senior Medical Director Pipeline Innovation, Neuroscience | $340,000–$374,000 | Horsham, PA | Mar 18, 2024 | Jul 29, 2025 | Sètifye | 498 |
| Manager, Real World Value & Evidence (REV&E), Oncology | $155,000–$165,000 | Horsham, PA | Jan 17, 2024 | May 20, 2025 | Sètifye | 489 |
| Manager, Market Access Analytics | $145,000–$155,000 | Titusville, NJ | Nov 22, 2023 | Apr 2, 2025 | Sètifye, ekspiré | 497 |
Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).